TP53 and rectal cancer: Yang et al. performed the whole-genome sequencing of 28 paired advanced rectal cancer specimens before and after CRT and observed that mutations in CTDSP2, APC, KRAS, TP53, and NFKBIZ confer selective pressure on cancer cells, resulting in resistance to CRT [12].